News Article | May 4, 2017
SALT LAKE CITY--(BUSINESS WIRE)--Clinical Innovations, one of the largest medical device companies exclusively focused on labor and delivery and the neonatal intensive care unit, will be attending the American College of Obstetricians and Gynecologists (ACOG) 65th Annual Clinical and Scientific Meeting, which takes place at the San Diego Convention Center in San Diego, California from May 6 – 9. With this year’s conference focus on “the Next Generation of Healthcare,” the ACOG Annual Meeting provides obstetricians and gynecologists the latest educational programming, networking sessions and scientific information to benefit patients and provide leadership in an evolving industry. As a market leader in healthcare marketing and manufacturing for labor, delivery and neonatal products, Clinical Innovations continues its ongoing support of ACOG as a Platinum-level event sponsor, endorsing the organization’s focus on education, advocacy and quality health care for women. Clinical Innovations will also be exhibiting (Booth #1044) and sharing new product information and demonstrations of its industry-leading devices, including the ebb® Complete Tamponade System, an effective treatment for postpartum hemorrhage (PPH), released in April 2017. Attendees will have the opportunity to use and provide feedback on Clinical Innovations’ new low-fidelity, high-frequency PPH simulation trainer, or schedule onsite PPH training at their own facilities after the conference. “The next generation of healthcare is just as much about medical professionals as it is about the patients we serve,” said Jeff Bradford, vice president of global marketing for Clinical Innovations. “With our commitment to helping mothers and babies throughout the world, we’re always proud to participate with ACOG and its rich field of experts across all disciplines to support continued growth and innovation in healthcare delivery and patient outcomes for generations to come.” Clinical Innovations also continues its dedication to training and education at ACOG, supporting a three-hour hands-on operative delivery workshop on May 8, as well as the conference’s 10th Annual ACOG Medical Student Workshop with fellow product and clinical educators. Clinical Innovations is one of the largest medical device companies exclusively focused on labor and delivery and the neonatal intensive care unit. Already a market leader in several categories with products such as the Koala® Intrauterine Pressure Catheter; Kiwi® Vacuum-Assisted Delivery System; ROM Plus® Rupture of Membranes Test; traxi® Panniculus Retractor, ClearView Uterine Manipulator, babyLance Safety heel stick and recently added ebb Complete Tamponade System. Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Clinical Innovations is a Pritzker Group company. For more information, visit clinicalinnovations.com. Pritzker Group, founded by Tony and J.B. Pritzker, has three principal investment teams: Private Capital, which acquires and operates leading North America-based companies; Venture Capital, which provides early-stage and growth venture funding to technology companies throughout the United States; and Asset Management, which partners with top-performing investment managers across global public markets. Pritzker Group Private Capital acquires North America-based middle-market companies with leading positions in the manufactured products, services and health care sectors. The firm’s permanent, proprietary capital base allows for efficient decision making, broad flexibility with transaction structure and investment horizon, and alignment with management teams focused on creating long-term value. Pritzker Group brings significant resources, expertise and credibility in building businesses and is an ideal partner for entrepreneur- and family-owned companies. For more information, visit pritzkergroup.com.
News Article | November 22, 2016
Making sure students are evaluated is a major responsibility for school districts, and is a key milestone in getting students the special education services they need. Chronic national shortages and other obstacles—including seasonal spikes in student evaluation referrals—can greatly slow the process. In an effort to deliver psychoeducational assessments to students in a more timely manner, PresenceLearning—the leading provider of live, online special education related services—conducted an equivalency study to understand the outcomes of online delivery of the Houghton Mifflin Harcourt (HMH) Woodcock-Johnson® IV (WJ IV) Cognitive and Achievement batteries. PresenceLearning Clinical Innovations Manager, Stephanie Taylor, Ed.S., NCSP, recently published a white paper entitled, “New, Online Psychoeducational Assessments Facilitate Timely Evaluation & Placement of K-12 Students with Exceptionalities” to brief special education administrators about online psychoeducational assessments and the effectiveness of this delivery model. To download the free white paper, visit: http://www.presencelearning.com/resources/content-library/remote-online-administration-of-psychoeducational-assessments/. The white paper provides an overview of why school districts struggle to keep up with the volume of psychoeducational assessments required, and how this scenario affects practitioners, students, and school districts as a whole. The paper goes on to document how online psychoeducational assessments are conducted and describes in detail why they can benefit practitioners, students, and districts. Finally, the white paper summarizes the research methods behind—and the results of—PresenceLearning’s WJ IV equivalency study with HMH, and explains what the results mean for the future of online psychoeducational assessments. To learn more about PresenceLearning’s online psychoeducational assessments, watch this video explaining how it works. Schools can request more information here, or by emailing schools(at)presencelearning(dot)com. About PresenceLearning PresenceLearning (http://www.presencelearning.com) is the leader in the delivery of clinical services to schools via telehealth. PresenceLearning has provided over one million sessions of live, online speech-language therapy, occupational therapy, behavioral interventions and mental health services, diagnostic services and assessments, and early childhood services for children with special needs.
Pitts N.,Clinical Innovations
Advances in dental research | Year: 2011
The IADR Global Oral Health Inequalities Task Group on Dental Caries has synthesized current evidence and opinion to identify a five-year implementation and research agenda which should lead to improvements in global oral health, with particular reference to the implementation of current best evidence as well as integrated action to reduce caries and health inequalities between and within countries. The Group determined that research should: integrate health and oral health wherever possible, using common risk factors; be able to respond to and influence international developments in health, healthcare, and health payment systems as well as dental prevention and materials; and exploit the potential for novel funding partnerships with industry and foundations. More effective communication between and among the basic science, clinical science, and health promotion/public health research communities is needed. Translation of research into policy and practice should be a priority for all. Both community and individual interventions need tailoring to achieve a more equal and person-centered preventive focus and reduce any social gradient in health. Recommendations are made for both clinical and public health implementation of existing research and for caries-related research agendas in clinical science, health promotion/public health, and basic science.
Clinical Innovations | Date: 2016-12-21
Clinical Innovations | Date: 2014-06-30
A method is taught for the accurate determination of the premature rupture of membranes (PROM), defined as spontaneous rupture of membranes before the onset of uterine contractions. More specifically, a lateral flow assay strip tests for at least two antigens to greatly limit or eliminate the possibility of false negatives. A built in timer in the cassette holding the lateral flow assay further increases the accuracy of the test. A collection buffer vial with self-contained shipping and dropper caps and built in stand is also taught.
Clinical Innovations | Date: 2012-07-05
A cup-like structure for engaging a cervix of a patient includes a rim, and includes a base defining an aperture through which one or more tubular members of a uterine manipulator may extend into the uterus. The cup-like structure is made from one or more of a polyphthalamide (PPA) material and a polyetheretherketone (PEEK) material. A uterine manipulator including a cup-like structure is also disclosed.
Clinical Innovations | Date: 2013-03-15
A surgical instrument comprises a handle having a blade proximate a distal end of the handle. A blade edge inset from a mouth of the recess is exposed within the recess and faces at least partially toward a proximal end of the handle with the blade edge inset from a mouth of the recess. The distal end further comprises a point bounding a portion of the recess and facing at least partially toward the proximal end of the handle. Methods of use are also disclosed.
Clinical Innovations | Date: 2013-03-14
A cable comprises a circuit, a switching element and an input connection for engaging an output connection of a sensor, the switching element configured to selectively enable the circuit of the cable assembly to process an accepted output of at least one of at least two sensors providing differing acceptable outputs and to provide a signal output corresponding to the accepted sensor output for processing by a monitor. A sensor includes an initiation element structured to cause a switching element associated with an input connection of the cable to change a mode of operation of the switching element to selectively enable the circuit to process an output of the sensor accepted by the cable and to provide a signal output corresponding to the accepted sensor output. A system comprises a monitor and the cable including the circuit and the switching element. Methods of operation are also disclosed.
News Article | October 2, 2015
SALT LAKE CITY--(BUSINESS WIRE)--Clinical Innovations, the largest healthcare manufacturer exclusively focused on labor and delivery, will unveil the traxi® Panniculus Retractor at the International Federation of Gynecology and Obstetrics (FIGO) World Congress in Vancouver, beginning Oct. 4. This will mark the first worldwide trade show for the device, which is already in use in more than 280 hospitals throughout North America. As part of Clinical Innovations’ commitment to improving the lives of mothers and their babies throughout the world, the traxi Panniculus Retractor is a device used to safely and effectively hold the panniculus (or excess abdominal skin) during Cesarean delivery particularly on higher risk obese patients to ensure that surgical teams can focus on providing the best possible care. The traxi device will be one of many innovations in obstetrics and gynecology that will be presented at the FIGO World Congress, an event built around advancing and addressing the many issues that affect women’s health. FIGO is a worldwide non‐profit organization that represents obstetricians and gynecologists throughout 125 countries and territories. “Recognizing clinical needs and developing safe, reliable, intuitive solutions that can help improve outcomes is part of our core values,” said Jeffrey Bradford, Vice President, Global Marketing for Clinical Innovations. “The traxi device is just one example of our extensive product portfolio focused in labor and delivery. We look forward to sharing ideas and new solutions with clinicians at FIGO.” Of the approximately 7,000 expected attendees at the FIGO World Congress, nearly 30 percent will represent the Americas, 30 percent from Asia, 30 percent from Europe and roughly 10 percent from other areas of the world. Clinical Innovations is the largest healthcare manufacturer exclusively focused on labor and delivery. Already a market leader in several categories with products such as the Koala® Intrauterine Pressure Catheter and Kiwi® Vacuum-Assisted Delivery System, Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Clinical Innovations is a Pritzker Group company. For more information, visit clinicalinnovations.com.